Hydrobentizide/Olmesartan Medoxomil

氢苄噻嗪/奥美沙坦酯

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHydrobentizide/Olmesartan Medoxomil
Drug Alias NameOlmesartan + Hidroclorotiazida Aurobindo
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiotensin II Receptor Type 1 antagonists
TargetsAngiotensin II Receptor Type 1
Therapy Area/IndicationsEssential Hypertension
Global Approved IndicationsEssential Hypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2014/08/20
Country/TerritoryEU
CombinationsYes Olmesartan Medoxomil
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesAurobindo Pharma (Portugal), Unipessoal Limitada
China Registration ClassN/A

Develop Information

Active CompaniesAurobindo Pharma (Portugal), Unipessoal Limitada
Inactive CompaniesN/A
Active IndicationsEssential Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeC09DA08
Related LinksN/A